Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 20.64
(5.84%)
CNY 20.64
(5.84%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.11 Billion CNY | 7.46% |
| 2022 | 1.03 Billion CNY | 72.72% |
| 2021 | 601.26 Million CNY | 90.45% |
| 2020 | 315.71 Million CNY | 33.42% |
| 2019 | 236.63 Million CNY | 124.49% |
| 2018 | 105.41 Million CNY | 0.2% |
| 2017 | 105.2 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 806.16 Million CNY | -33.23% |
| 2024 Q1 | 1.19 Billion CNY | 6.9% |
| 2024 Q2 | 1.23 Billion CNY | 3.46% |
| 2023 FY | 1.11 Billion CNY | 7.46% |
| 2023 Q2 | 1.2 Billion CNY | 8.2% |
| 2023 Q1 | 1.11 Billion CNY | 7.0% |
| 2023 Q4 | 1.11 Billion CNY | -1.94% |
| 2023 Q3 | 1.13 Billion CNY | -5.34% |
| 2022 Q2 | 899.91 Million CNY | 19.09% |
| 2022 FY | 1.03 Billion CNY | 72.72% |
| 2022 Q4 | 1.03 Billion CNY | 7.71% |
| 2022 Q3 | 964.17 Million CNY | 7.14% |
| 2022 Q1 | 755.68 Million CNY | 25.68% |
| 2021 FY | 601.26 Million CNY | 90.45% |
| 2021 Q2 | 298.57 Million CNY | 15.41% |
| 2021 Q3 | 477.9 Million CNY | 60.06% |
| 2021 Q4 | 601.26 Million CNY | 25.81% |
| 2021 Q1 | 258.71 Million CNY | -18.06% |
| 2020 Q3 | 315.52 Million CNY | 6.48% |
| 2020 FY | 315.71 Million CNY | 33.42% |
| 2020 Q2 | 296.32 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 315.71 Million CNY | 0.06% |
| 2019 Q4 | 236.63 Million CNY | 0.0% |
| 2019 FY | 236.63 Million CNY | 124.49% |
| 2018 FY | 105.41 Million CNY | 0.2% |
| 2017 FY | 105.2 Million CNY | 0.0% |